INFLAMMATORY BOWEL DISEASE

This study tested whether a web-based telemonitoring system (TECCU) helps people with moderate-to-severe inflammatory bowel disease (Crohn's disease or ulcerative colitis) stay in remission longer than standard care. 290 adults who needed immunosuppressants or biologics were foll…

This study looked at whether a special liquid diet (elemental diet) can change gut bacteria and improve stomach and bowel symptoms in people with chronic granulomatous disease (CGD) and inflammatory bowel disease (IBD). Three participants aged 8 to 65 followed the diet for up to …

This study compared two ways of delivering care to 657 people with inflammatory bowel disease (IBD) who also had mild to severe behavioral health symptoms like anxiety or depression. One approach used in-person support, while the other used technology-based care. The goal was to …

This study looked at whether regular moderate physical activity can reduce chronic fatigue and improve quality of life in people with inactive inflammatory bowel disease (IBD). Only 3 participants completed the program. The researchers measured fatigue and quality of life before …

This study looked at 150 adults with Crohn's disease who had narrowings in the small intestine (strictures) but no symptoms. Researchers reviewed medical records to see how often these silent strictures caused problems like pain or bloating, and whether patients needed treatment.…

This study looked at how much of the drug risankizumab passes into breast milk of women with inflammatory bowel disease (IBD). Ten mothers who were already taking risankizumab every 8 weeks after giving birth provided milk samples. The goal was to understand infant exposure and c…

This study looked at whether simple stool tests (calprotectin and fecal immunochemical test) can accurately show if inflammatory bowel disease (IBD) is active or in remission, compared to the standard colonoscopy. Researchers studied 120 adults with IBD who were scheduled for col…

This early-stage study tested a single dose of the SM17 antibody in 30 healthy Chinese adults to see if it is safe and how the body processes it. The goal was not to treat any disease, but to gather important safety and drug-level information. No direct benefit was expected for p…